A kind of pH-sensitive drug-loaded particle and its preparation method and application
A drug-loading and particle technology, applied in the field of medicine, can solve problems such as low anticoagulant heparin modifiers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Embodiment 1 Preparation of low anticoagulant heparin
[0030] Dissolve 20 g of heparin sodium (molecular weight 1.2 to 2.8 Daltons) in 175 ml of deionized water, adjust the pH of the solution to 5 with 1N HCl, add sodium periodate (NaIO 4 ) 15g, the solution was adjusted to 500ml with deionized water, and the pH of the solution was adjusted to 5 with 1N HCl. Reaction at 4°C for 24h. Dialyze in deionized water to obtain 1.5 L of dialysate, add 32 ml of 10N NaOH aqueous solution, and react in the dark at room temperature for 3 h. Then sodium borohydride (NaBH 4 ) 1 g, after reacting at room temperature for 4 h, the solution was neutralized to pH 7.0. Add 2.54 L of ethanol, let it stand for 3 hours, precipitate out, and re-purify with ethanol, and dry the precipitated solid under reduced pressure to obtain 9.8 g of low anticoagulant heparin, with a yield of 49%. 1 HNMR such as figure 2 shown.
Embodiment 2
[0031] Embodiment 2 Preparation of low anticoagulant heparin modification
[0032] Pass 10 g of low anticoagulant heparin prepared in Example 1 through a resin column, add 20 mg of tributylamine to form a salt, evaporate under reduced pressure to obtain 13 g of heparin salt, add the salt-formed substance to 110 mL of DMF solvent, add 0.1 mL of acetic anhydride and 0.7 g dicyclohexylcarbodiimide (DCC), stirred and reacted at room temperature for 48 hours, added 30 mL of alkaline aqueous solution to terminate the reaction and hydrolyzed the product, filtered to remove solids, dialyzed to remove impurities, added 5 L of ethanol to the dialysate, and obtained a precipitate. The above precipitate is low anticoagulant heparin modification, 1 HNMR such as image 3 shown.
[0033] The low anticoagulant heparin modification (hereinafter referred to as heparin modification) involved in the following examples all use the product of Example 2.
Embodiment 3
[0034] The preparation of embodiment 3 camptothecin nanoparticles freeze-dried powder
[0035] Dissolve 4mg of camptothecin in 1mL of 0.00004% NaOH aqueous solution, add 8mg of modified heparin, and ultrasonically emulsify for 10min at 25°C and 20KHz ultrasonic conditions to obtain a mixed solution; pass the mixed solution through a 0.22μm microporous membrane to obtain a microemulsion with a particle size of 60-200nm; freeze-dry the microemulsion at -20°C to obtain a freeze-dried powder of camptothecin nanoparticles.
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



